Health
Preventing and Treating Cardiotoxicity in Patients With Breast Cancer Involves Aggressive Monitoring, Management Strategies – Cancer Network
Mandar Aras, MD, PhD, discussed the management and prevention of cardiotoxicity in patients receiving systemic therapy for breast cancer at the 38th Annual Miami…
Cardiac dysfunction is a prominent concern in patients receiving therapy for breast cancer, especially those with HER2-positive disease who may receive targeted therapies and have a history of prior anthracyclines exposure.
In a presentation at the 38th Annual Miami Breast Cancer Conference, hosted by Physicians Education Resource®, LLC, Mandar Aras, MD, PhD, of the University of California San Francisco, discussed best strategies for treating these patients, which includes consistent monitoring…
-
Business14 hours agoWarning! These ASX 200 shares were just downgraded
-
Business12 hours ago2 monthly payers you’ll want to own in 2025 and beyond
-
General23 hours agoTelco Exetel fined $694K after scammers bypass verification processes, access bank accounts
-
General10 hours agoFatal house fire at Lake Illawarra under police investigation